KEMPHARM, INC KMPH Income Statement

Kempharm, inc (KMPH)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Revenue
2,089	-	11,463	-	0	-	0	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Operating expenses:
Royalty and direct contract acquisition costs
663	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenue
-	-	1,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
2,126	2,465	3,616	4,803	8,531	6,304	13,330	10,488	11,637	5,536	6,293	4,650	4,114	7,963	4,287	4,988	3,234	4,716	4,328	2,768	2,119	5,911	3,253	1,715	1,038
General and administrative
2,245	1,376	3,613	2,989	2,838	2,964	2,992	3,420	3,132	2,614	3,319	3,574	3,266	2,873	3,104	4,287	3,736	2,566	2,152	3,188	977	1,577	1,086	1,330	534
Severance expense
830	-	-	-	-	-	1,636	-	-	0	0	-	-	0	3,010	0	0	-	-	-	-	-	-	-	-
Total operating expenses
5,864	-	8,229	-	11,369	-	17,958	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
-	-	-	7,792	-	-	-	13,908	14,769	8,150	9,612	8,224	7,380	10,836	10,401	9,275	6,970	7,282	6,480	5,956	3,096	7,488	4,339	3,045	1,572
Loss from operations
-3,775	-4,410	3,234	-7,792	-11,369	-9,268	-17,958	-13,908	-14,769	-8,150	-9,612	-8,224	-7,380	-10,836	-10,401	-9,275	-6,970	-7,282	-6,480	-5,956	-3,096	-7,488	-4,339	-3,045	-1,572
Other (expense) income:
Gain on extinguishment of debt
-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	0	-4,740	0	0	0	0	-	-	1,900	-
Interest expense related to amortization of debt issuance costs and discount
571	675	371	305	305	512	326	390	390	390	391	390	390	391	390	393	442	475	479	477	477	478	477	159	0
Interest expense on principal
1,260	1,189	1,208	1,232	1,229	1,241	1,367	1,419	1,442	1,444	1,448	1,443	1,441	1,445	1,441	1,475	1,150	698	687	654	632	631	173	704	96
Fair value adjustment related to derivative and warrant liability
-75	-215	-1,351	21	-453	-5,687	-4,468	-5,562	9,741	710	-1,312	-3,523	7,216	-2,723	1,299	-20,763	-10,278	764	2,089	22,661	1,762	3,221	2,189	1,570	242
Interest and other (expense) income, net
-223	-	-	-	151	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income, net
-	-	60	84	-	130	52	123	115	97	154	13	101	9	98	144	102	15	11	5	0	4	3	-	-
Total other (expense) income
-1,979	-1,635	-168	-1,474	-930	4,066	2,827	3,876	-11,458	-2,447	-373	1,703	-8,946	896	-3,032	19,039	4,048	-1,922	-3,244	-23,787	-2,871	-4,326	-2,836	-533	-338
Loss before income taxes
-5,754	-6,045	3,066	-9,266	-12,299	-5,202	-15,131	-10,032	-26,227	-10,597	-9,985	-6,521	-16,326	-9,940	-13,433	9,764	-2,922	-9,204	-9,724	-29,743	-5,967	-11,814	-7,175	-3,578	-1,910
Income tax benefit
-	-8	3	-9	-8	-19	-60	-39	-8	-31	-4	-4	-4	-4	-19	-4	12	-1	20	0	7	27	-38	-6	-5
Net loss
-5,754	-6,037	3,063	-9,257	-12,291	-5,183	-15,071	-9,993	-26,219	-10,566	-9,981	-6,517	-16,322	-9,936	-13,414	9,768	-2,934	-9,203	-9,744	-29,743	-5,974	-11,841	-7,137	-3,572	-1,905
Net loss per share of common stock:
Basic and diluted (in dollars per share)
-0.12	-	-	-	-0.46	-	-	-	-1.77	-	-0.68	-	-1.11	-	-	-	-	-	-	-	-	-4.97	-3.00	-1.50	-0.80
Basic (in dollars per share)
-	-	0.09	-0.33	-	-	-0.94	-0.65	-	-	-	-0.44	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in dollars per share)
-	-	0.06	-0.33	-	-	-0.94	-0.91	-	-	-	-0.44	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average number of shares of common stock outstanding:
Basic and diluted (in shares)
48,073	-	-	-	26,701	-	-	-	14,791	-	14,657	-	14,646	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	30,126	28,386	-	-	16,033	15,317	-	-	-	14,649	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
-	-	31,672	28,386	-	-	16,033	16,548	-	-	-	14,649	-	-	-	-	-	-	-	-	-	-	-	-	-